These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

781 related items for PubMed ID: 18316609

  • 1. EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma.
    Yamashita T, Forgues M, Wang W, Kim JW, Ye Q, Jia H, Budhu A, Zanetti KA, Chen Y, Qin LX, Tang ZY, Wang XW.
    Cancer Res; 2008 Mar 01; 68(5):1451-61. PubMed ID: 18316609
    [Abstract] [Full Text] [Related]

  • 2. Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma.
    Yamashita T, Budhu A, Forgues M, Wang XW.
    Cancer Res; 2007 Nov 15; 67(22):10831-9. PubMed ID: 18006828
    [Abstract] [Full Text] [Related]

  • 3. EpCAM, a new marker for cancer stem cells in hepatocellular carcinoma.
    Terris B, Cavard C, Perret C.
    J Hepatol; 2010 Feb 15; 52(2):280-1. PubMed ID: 20006402
    [Abstract] [Full Text] [Related]

  • 4. Angiogenesis and clinicopathologic characteristics in different hepatocellular carcinoma subtypes defined by EpCAM and α-fetoprotein expression status.
    Shan YF, Huang YL, Xie YK, Tan YH, Chen BC, Zhou MT, Shi HQ, Yu ZP, Song QT, Zhang QY.
    Med Oncol; 2011 Dec 15; 28(4):1012-6. PubMed ID: 20571936
    [Abstract] [Full Text] [Related]

  • 5. EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features.
    Yamashita T, Ji J, Budhu A, Forgues M, Yang W, Wang HY, Jia H, Ye Q, Qin LX, Wauthier E, Reid LM, Minato H, Honda M, Kaneko S, Tang ZY, Wang XW.
    Gastroenterology; 2009 Mar 15; 136(3):1012-24. PubMed ID: 19150350
    [Abstract] [Full Text] [Related]

  • 6. The transcription factor SALL4 regulates stemness of EpCAM-positive hepatocellular carcinoma.
    Zeng SS, Yamashita T, Kondo M, Nio K, Hayashi T, Hara Y, Nomura Y, Yoshida M, Hayashi T, Oishi N, Ikeda H, Honda M, Kaneko S.
    J Hepatol; 2014 Jan 15; 60(1):127-34. PubMed ID: 24012616
    [Abstract] [Full Text] [Related]

  • 7. Oncostatin m renders epithelial cell adhesion molecule-positive liver cancer stem cells sensitive to 5-Fluorouracil by inducing hepatocytic differentiation.
    Yamashita T, Honda M, Nio K, Nakamoto Y, Yamashita T, Takamura H, Tani T, Zen Y, Kaneko S.
    Cancer Res; 2010 Jun 01; 70(11):4687-97. PubMed ID: 20484035
    [Abstract] [Full Text] [Related]

  • 8. High expression of MAGE-A9 contributes to stemness and malignancy of human hepatocellular carcinoma.
    Wei Y, Wang Y, Gong J, Rao L, Wu Z, Nie T, Shi D, Zhang L.
    Int J Oncol; 2018 Jan 01; 52(1):219-230. PubMed ID: 29138811
    [Abstract] [Full Text] [Related]

  • 9. Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells.
    Ji J, Yamashita T, Budhu A, Forgues M, Jia HL, Li C, Deng C, Wauthier E, Reid LM, Ye QH, Qin LX, Yang W, Wang HY, Tang ZY, Croce CM, Wang XW.
    Hepatology; 2009 Aug 01; 50(2):472-80. PubMed ID: 19585654
    [Abstract] [Full Text] [Related]

  • 10. Expression and role of epithelial cell adhesion molecule in dysplastic nodule and hepatocellular carcinoma.
    Bae JS, Noh SJ, Jang KY, Park HS, Chung MJ, Park CK, Moon WS.
    Int J Oncol; 2012 Dec 01; 41(6):2150-8. PubMed ID: 22993038
    [Abstract] [Full Text] [Related]

  • 11. Expression of epithelial cell adhesion molecule associated with elevated ductular reactions in hepatocellar carcinoma.
    Xu M, Qian G, Xie F, Shi C, Yan L, Yu L, Zheng T, Wei L, Yang J.
    Clin Res Hepatol Gastroenterol; 2014 Dec 01; 38(6):699-705. PubMed ID: 24924904
    [Abstract] [Full Text] [Related]

  • 12. Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection.
    Sun YF, Xu Y, Yang XR, Guo W, Zhang X, Qiu SJ, Shi RY, Hu B, Zhou J, Fan J.
    Hepatology; 2013 Apr 01; 57(4):1458-68. PubMed ID: 23175471
    [Abstract] [Full Text] [Related]

  • 13. Identification of microRNAs specific for epithelial cell adhesion molecule-positive tumor cells in hepatocellular carcinoma.
    Ji J, Zheng X, Forgues M, Yamashita T, Wauthier EL, Reid LM, Wen X, Song Y, Wei JS, Khan J, Thorgeirsson SS, Wang XW.
    Hepatology; 2015 Sep 01; 62(3):829-40. PubMed ID: 25953724
    [Abstract] [Full Text] [Related]

  • 14. Presence of EpCAM-positive circulating tumor cells as biomarker for systemic disease strongly correlates to survival in patients with hepatocellular carcinoma.
    Schulze K, Gasch C, Staufer K, Nashan B, Lohse AW, Pantel K, Riethdorf S, Wege H.
    Int J Cancer; 2013 Nov 01; 133(9):2165-71. PubMed ID: 23616258
    [Abstract] [Full Text] [Related]

  • 15. Prognostic relevance of miR-137 in patients with hepatocellular carcinoma.
    Sakabe T, Azumi J, Umekita Y, Toriguchi K, Hatano E, Hirooka Y, Shiota G.
    Liver Int; 2017 Feb 01; 37(2):271-279. PubMed ID: 27473646
    [Abstract] [Full Text] [Related]

  • 16. Integrative genomics identifies YY1AP1 as an oncogenic driver in EpCAM(+) AFP(+) hepatocellular carcinoma.
    Zhao X, Parpart S, Takai A, Roessler S, Budhu A, Yu Z, Blank M, Zhang YE, Jia HL, Ye QH, Qin LX, Tang ZY, Thorgeirsson SS, Wang XW.
    Oncogene; 2015 Sep 24; 34(39):5095-104. PubMed ID: 25597408
    [Abstract] [Full Text] [Related]

  • 17. Hepatic progenitor cells in liver cancers from Asian children.
    Ward SC, Thung SN, Lim KH, Tran TT, Hong TK, Hoang PL, Jang JJ, Park YN, Abe K.
    Liver Int; 2010 Jan 24; 30(1):102-11. PubMed ID: 19793197
    [Abstract] [Full Text] [Related]

  • 18. Human hepatocellular carcinomas with "Stemness"-related marker expression: keratin 19 expression and a poor prognosis.
    Kim H, Choi GH, Na DC, Ahn EY, Kim GI, Lee JE, Cho JY, Yoo JE, Choi JS, Park YN.
    Hepatology; 2011 Nov 24; 54(5):1707-17. PubMed ID: 22045674
    [Abstract] [Full Text] [Related]

  • 19. Expression of stemness markers (CD133 and EpCAM) in prognostication of hepatocellular carcinoma.
    Chan AW, Tong JH, Chan SL, Lai PB, To KF.
    Histopathology; 2014 Jun 24; 64(7):935-50. PubMed ID: 24506513
    [Abstract] [Full Text] [Related]

  • 20. Discrete nature of EpCAM+ and CD90+ cancer stem cells in human hepatocellular carcinoma.
    Yamashita T, Honda M, Nakamoto Y, Baba M, Nio K, Hara Y, Zeng SS, Hayashi T, Kondo M, Takatori H, Yamashita T, Mizukoshi E, Ikeda H, Zen Y, Takamura H, Wang XW, Kaneko S.
    Hepatology; 2013 Apr 24; 57(4):1484-97. PubMed ID: 23174907
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.